Codes / ICD10CM / K63.81

K63.81 Dieulafoy lesion of intestine

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Dieulafoy lesion of intestine

Summary

Dieulafoy lesion of the intestine is a rare vascular abnormality characterized by a dilated, tortuous submucosal artery that can cause significant gastrointestinal bleeding. This condition typically presents with sudden, severe bleeding, often without preceding symptoms, and may require prompt medical or surgical intervention to manage.

Causes

The exact cause of Dieulafoy lesion is not fully understood, but it is thought to result from a congenital or acquired abnormality in the submucosal arterial structure. The lesion may be triggered by factors such as increased intra-abdominal pressure, trauma, or inflammation, which can lead to vessel rupture and bleeding.

Risk Factors

  • Advanced age
  • Use of nonsteroidal anti-inflammatory drugs (NSAIDs)
  • Chronic alcohol use
  • History of gastrointestinal bleeding
  • Underlying vascular conditions

Symptoms

  • Sudden, severe gastrointestinal bleeding
  • Hematemesis (vomiting blood)
  • Melena (black, tarry stools)
  • Hematochezia (bright red blood in stools)
  • Abdominal pain or discomfort
  • Dizziness or lightheadedness from blood loss

Diagnosis

Diagnosis involves a combination of clinical evaluation and diagnostic testing. Healthcare providers typically review medical history and perform physical examinations. Endoscopic procedures, such as upper or lower gastrointestinal endoscopy, are often used to visualize the lesion directly. Imaging studies like angiography may be employed to identify the vascular abnormality if endoscopy is inconclusive.

Treatment Options

  • Endoscopic hemostasis (e.g., clipping, coagulation)
  • Angiographic embolization to stop bleeding
  • Surgical resection of the affected segment (in severe cases)
  • Blood transfusions to manage anemia or hypovolemia
  • Medications to reduce gastric acid or promote healing

Prognosis and Follow-Up

The prognosis for Dieulafoy lesion is generally good with timely intervention, though recurrent bleeding can occur. Follow-up care may include repeat endoscopy to monitor for recurrence and ongoing management of underlying risk factors. Long-term outcomes depend on the severity of the initial bleed and the effectiveness of treatment.

Complications

  • Severe or recurrent gastrointestinal bleeding
  • Hypovolemic shock from significant blood loss
  • Anemia due to chronic blood loss
  • Perforation of the intestinal wall (rare)
  • Infection or sepsis (if surgical intervention is required)

Lifestyle & Prevention

  • Avoiding NSAIDs or using them cautiously under medical supervision
  • Limiting alcohol consumption
  • Maintaining a balanced diet to support gastrointestinal health
  • Promptly addressing any symptoms of gastrointestinal bleeding
  • Regular medical check-ups for those with risk factors

When to Seek Professional Help

Seek immediate medical attention if you experience:

  • Sudden, severe abdominal pain
  • Vomiting blood or passing black, tarry stools
  • Dizziness, fainting, or signs of shock (e.g., rapid heartbeat, pale skin)
  • Unexplained weight loss or persistent gastrointestinal symptoms

Tips for Medical Coders

When coding for Dieulafoy lesion of the intestine (K63.81), ensure documentation supports the diagnosis, including endoscopic findings, imaging results, or surgical reports. Note any associated complications, such as bleeding or anemia, as these may require additional codes. Verify that the lesion is specifically identified as intestinal, as the code is distinct from gastric or other gastrointestinal locations.

Medical Policies and Guidelines

Related policies from health plans

Serum iron Testing
CG-LAB-21 Serum Iron Testing
Book a walkthrough

K63.81 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.